ArticleOsteoarthritis and cartilage open2026
Serum leptin, adiposity, and their link to symptomatic hand osteoarthritis in individuals with radiological signs - A cross-sectional HALLOA cohort study.
Article in Osteoarthritis and cartilage open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the relationship between serum leptin levels and symptomatic hand osteoarthritis (OA) in individuals with radiographically confirmed hand OA. Method: This cross-sectional study included 90 individuals with radiographically confirmed hand OA. Symptomatic hand OA was diagnosed according to the American College of Rheumatology (ACR) criteria. Serum leptin levels, body mass index (BMI), and bioimpedance were measured. Participants reported pain intensity in the Numeric Rating Scale (NRS), self-reported upper-extremity disability (QuickDASH), number of bodily pain sites, and underwent pain pressure threshold (PPT) and grip strength measurements. Characteristics were compared between individuals with and without symptomatic hand OA. Binary logistic regressions were used to investigate the relationship between serum leptin levels and symptomatic hand OA. Adjustments were made stepwise for 1. age and sex, 2. adiposity, 3. radiographic severity of hand OA, and 4. PPT. Results: Symptomatic hand OA was diagnosed in 51 participants, whereas 39 did not have symptomatic hand OA. Participants with symptomatic hand OA had more hand pain, worse function, weaker grip, but also lower PPTs and more bodily pain. Metabolic factors did not differ between groups. Serum leptin levels were not associated with symptomatic hand OA. In a secondary finding, female sex was associated with symptomatic hand OA, an effect that was attenuated after adjustment for PPTs. Conclusion: Compared to those without symptoms, participants with symptomatic hand OA had lower PPTs and more widespread pain, consistent with features of central sensitization. While serum leptin was not independently associated with symptomatic hand OA, differences in pain sensitivity may contribute to the higher prevalence of symptomatic hand OA among women.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.